New blood biomarker identified for status of fatty liver disease

A MedUni Vienna study team has identified the role of a specific subtype of macrophages (white blood cells) in progressive non-alcoholic fatty liver disease. As part of the immune system, these cells have a protective function against fibrosis and liver cirrhosis. At the same time, they are useful as biomarkers of liver disease progression as they can be measured by a blood test. The results were recently published in the Journal of Hepatology.

source https://medicalxpress.com/news/2022-06-blood-biomarker-status-fatty-liver.html